Anixa Biosciences, Inc. - ANIX
About Gravity Analytica
Recent News
- 03.11.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
- 03.10.2025 - Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
- 03.03.2025 - Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th
- 02.26.2025 - Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial
- 02.25.2025 - Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports"
- 02.24.2025 - Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer
- 02.18.2025 - Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
- 02.14.2025 - Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview
- 02.11.2025 - Anixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum
- 02.06.2025 - DEF 14A - Definitive proxy statements